Veerix Biotech is a WHO-GMP certified third-party pharmaceutical manufacturer and CDMO partner producing VEERIX-ROSUVASTATIN Capsules (ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN (AS PELLETS) , CLPIDOGREL BISULPHATE IP EQ. TO CLOPIDOGREL (AS PELLETS) HARD GELATIN CAPSULE SYRUP/SUSPENSION) within the Cardiac therapeutic class, with complete Certificate of Analysis (CoA), stability studies, and regulatory dossier compliance for domestic Indian and global export markets.
| Product Name | VEERIX-ROSUVASTATIN Capsules |
| Active Composition | ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN (AS PELLETS) , CLPIDOGREL BISULPHATE IP EQ. TO CLOPIDOGREL (AS PELLETS) HARD GELATIN CAPSULE SYRUP/SUSPENSION |
| Therapeutic Segment | Cardiac |
| Dosage Form | Capsules |
| Primary Packaging | 10*10 Capsules |
| Quality Standard | IP / BP / USP Pharmacopeial Standard, WHO-GMP Certified |
| Manufacturing Facility | Tahliwal Industrial Area, Tehsil Haroli, Una, Himachal Pradesh & Coimbatore, Tamil Nadu |
| Regulatory Documentation | Batch Release CoA, Method of Analysis (MOA), Accelerated & Real-time Stability Data, CTD Module 3 |
Veerix Biotech provides end-to-end commercial supply and technical scoping for VEERIX-ROSUVASTATIN Capsules in the Cardiac class. From pre-formulation screening and pilot batch validation to automated blister packaging, serialisation, and multi-market regulatory clearance, our direct facilities and audited partner network ensure seamless execution.